HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.

AbstractOBJECTIVE:
Metabolic syndrome (MetS) is associated with insulin resistance and increases the cardiovascular risk. Oxidative stress constitutes a potential mechanism that links insulin resistance and cardiovascular disease. The aim of this study was to analyze the relationship of NADPH oxidase activation with insulin resistance, and the effect of this interaction on the cardiovascular risk in MetS patients.
METHODS:
NADPH oxidase-dependent superoxide production and expression was evaluated by luminescence and western blot, respectively, in peripheral blood mononuclear cells obtained from 125 patients with MetS. Insulin resistance was defined by the homeostasis model assessment index. Matrix metalloproteinase-9 was quantified by enzyme-linked immunosorbent assay in plasma samples. To ascertain the mechanisms involved in vivo, we performed in-vitro experiments in cultured macrophages.
RESULTS:
Fifty-six percent of patients with MetS showed insulin resistance. Plasma matrix metalloproteinase-9 levels were higher (P < 0.05) in insulin-resistant patients than in patients with insulin sensitivity. NADPH oxidase-dependent superoxide production was augmented (P < 0.05) in insulin-resistant patients with respect to insulin-sensitive patients. The interaction between insulin resistance and abnormally high NADPH oxidase-mediated superoxide production was associated with the highest matrix metalloproteinase-9 values. Increased NADPH oxidase-dependent superoxide production was significantly associated with higher NADPH oxidase p22phox expression in insulin-resistant than in insulin-sensitive patients. Interestingly, insulin upregulated p22phox in peripheral blood mononuclear cells and in murine macrophages.
CONCLUSION:
Insulin resistance is associated with phagocytic NADPH oxidase activation. This association results in the highest cardiovascular risk in MetS patients.
AuthorsAna Fortuño, Julen Bidegain, Gorka San José, Pablo A Robador, Manuel F Landecho, Oscar Beloqui, Javier Díez, Guillermo Zalba
JournalJournal of hypertension (J Hypertens) Vol. 27 Issue 7 Pg. 1420-30 (Jul 2009) ISSN: 1473-5598 [Electronic] England
PMID19357530 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Superoxides
  • NADPH Oxidases
Topics
  • Animals
  • Cell Line
  • Enzyme Activation
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Insulin Resistance
  • Male
  • Metabolic Syndrome (enzymology, physiopathology)
  • Mice
  • Middle Aged
  • NADPH Oxidases (metabolism)
  • Oxidative Stress
  • Phagocytes (enzymology)
  • Superoxides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: